Clinical characteristics, outcomes, and costs of COVID-19 patients in Thai hospitels: a comparative analysis based on chest X-ray findings.

Publication date: Jan 09, 2025

“Hospitels” are hotels that have been specially converted to healthcare facilities. Their utilization emerged as a resource-optimization strategy during the peak of the COVID-19 pandemic in Thailand. This study evaluated the clinical characteristics, outcomes, and admission costs of asymptomatic and mild-to-moderate COVID-19 patients treated in these facilities. We conducted a retrospective analysis of adult COVID-19 patients who were admitted between July and October 2021 to two hospitels in Bangkok that were affiliated with Siriraj Hospital. Patient demographics, clinical data, vaccination status, treatment modalities, outcomes, and total costs were collected and analyzed via univariable and multivariable statistical methods. Of the 1729 patients, 644 (37. 2%) presented with abnormal baseline chest X-rays that could imply to moderate cases. These patients were older (49. 2 vs. 42. 2 years, P 

Open Access PDF

Concepts Keywords
Healthcare Chest X-ray
July COVID-19
October Hospitel
Pandemic Pneumonia
Thailand Thailand

Semantics

Type Source Name
disease MESH COVID-19
pathway REACTOME Reproduction
disease MESH Infectious Diseases
drug DRUGBANK Coenzyme M
disease MESH comorbidity
disease MESH respiratory failure
disease MESH morbidity
disease MESH infections
disease MESH hypoxia
drug DRUGBANK Trestolone
drug DRUGBANK Oxygen
disease IDO infection
disease MESH emergency
disease MESH Pneumonia
disease MESH lung disease
disease MESH cardiovascular disease
disease MESH congenital heart disease
disease MESH diabetes mellitus
disease MESH cerebrovascular disease
disease MESH malignancy
disease MESH cirrhosis
disease IDO process
drug DRUGBANK Acetaminophen
drug DRUGBANK Favipiravir
drug DRUGBANK Etoperidone
disease IDO blood
drug DRUGBANK Dexamethasone
disease IDO site
disease MESH Hypertension
disease MESH Dyslipidemia
disease MESH Obesity
disease MESH HIV infection
pathway REACTOME HIV Infection
disease MESH Asthma
pathway KEGG Asthma
disease MESH Sore throat
disease MESH Anosmia
disease IDO immunodeficiency
disease IDO ribonucleic acid
disease MESH upper respiratory tract infection
disease IDO symptom
disease MESH complications
disease MESH Acute Respiratory Distress Syndrome

Original Article

(Visited 3 times, 1 visits today)